EXCLUSIVE: ImmunoPrecise Antibodies Tells Benzinga 'This Collaboration Integrates the New Vector Search Capability of the InterSystems IRIS Data Platform With IPA's Subsidiary BioStrand's LENS Platform for AI-driven Applications in Healthcare'
EXCLUSIVE: ImmunoPrecise Antibodies Tells Benzinga 'This Collaboration Integrates the New Vector Search Capability of the InterSystems IRIS Data Platform With IPA's Subsidiary BioStrand's LENS Platform for AI-driven Applications in Healthcare'
獨家：ImmunoPrecise 抗體告訴 Benzinga “此次合作將InterSystems IRIS數據平台的新載體搜索功能與IPA子公司BioStrand的LENS平台整合在一起，用於人工智能驅動的醫療保健應用”
EXCLUSIVE: ImmunoPrecise Antibodies Tells Benzinga 'This Collaboration Integrates the New Vector Search Capability of the InterSystems IRIS Data Platform With IPA's Subsidiary BioStrand's LENS Platform for AI-driven Applications in Healthcare'
獨家：ImmunoPrecise 抗體告訴 Benzinga “此次合作將InterSystems IRIS數據平台的新載體搜索功能與IPA子公司BioStrand的LENS平台整合在一起，用於人工智能驅動的醫療保健應用”
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。